期刊
EXPERIMENTAL BIOLOGY AND MEDICINE
卷 239, 期 3, 页码 302-310出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1535370213514927
关键词
docosahexaenoic acid; butyrate; apoptosis; DNA methylation; epigenetics
资金
- NSBRI NASA [NCC 9-58]
- NASA [NAG-9-1523]
- NIH [CA59034, CA129444, CA90301, CA057030, CA168312, CA61750]
DNA methylation and histone acetylation contribute to the transcriptional regulation of genes involved in apoptosis. We have demonstrated that docosahexaenoic acid (DHA, 22:6 n-3) and butyrate enhance colonocyte apoptosis. To determine if DHA and/ or butyrate elevate apoptosis through epigenetic mechanisms thereby restoring the transcription of apoptosis-related genes, we examined global methylation; gene-specific promoter methylation of 24 apoptosis-related genes; transcription levels of Cideb, Dapk1, and Tnfrsf25; and global histone acetylation in the HCT-116 colon cancer cell line. Cells were treated with combinations of (50 mu M) DHA or linoleic acid (18:2 n-6), (5mM) butyrate or an inhibitor of DNA methyltransferases, and 5-aza- 2'-deoxycytidine (5-Aza-dC, 2 mu M). Among highly methylated genes, the combination of DHA and butyrate significantly reduced methylation of the proapoptotic Bcl2l11, Cideb, Dapk1, Ltbr, and Tnfrsf25 genes compared to untreated control cells. DHA treatment reduced the methylation of Cideb, Dapk1, and Tnfrsf25. These data suggest that the induction of apoptosis by DHA and butyrate is mediated, in part, through changes in the methylation state of apoptosis-related genes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据